{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:11:49Z","timestamp":1793391109005,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    PRKAG2 syndrome is a rare autosomal dominant inherited disorder that is characterized by cardiac hypertrophy, ventricular pre-excitation and conduction system abnormalities. There is little knowledge in cardiovascular magnetic resonance (CMR) characteristics of PRKAG2 cardiomyopathy. This study investigated the genetic defect in a three-generation Chinese family with cardiac hypertrophy and ventricular pre-excitation using whole-exome sequencing. A novel missense mutation, c.1006\u2009G\u2009&gt;\u2009T (p.V336L), was identified in\n                    <jats:italic>PRKAG2<\/jats:italic>\n                    . This mutation had not been identified in the ExAC database, and the prediction result of MutationTaster indicated a deleterious effect. Furthermore, it cosegregated with the disease in the present family and was absent in unrelated 300 healthy controls. cDNA analysis did not detect any splicing defects, although the variant occurred in the first base of exon 9. CMR evaluation in five affected members showed diffuse hypertrophy in a concentric pattern, with markedly increased left ventricular mass above age and gender limits (median 151.3\u2009g\/m\n                    <jats:sup>2<\/jats:sup>\n                    , range 108.4\u2013233.4\u2009g\/m\n                    <jats:sup>2<\/jats:sup>\n                    ). Two patients in progressive stage and one patient with sudden cardiac death exhibited extensive subendocardial late gadolinium enhancement. In conclusion, molecular screening for\n                    <jats:italic>PRKAG2<\/jats:italic>\n                    mutations should be considered in patients who exhibit cardiac hypertrophy coexisting with ventricular pre-excitation. CMR offers promising advantages for evaluation of PRKAG2 cardiomyopathy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-02455-z","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T06:30:14Z","timestamp":1495175414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation"],"prefix":"10.1038","volume":"7","author":[{"given":"Kun-Qi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Xia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"2455_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","volume":"10","author":"E Blair","year":"2001","unstructured":"Blair, E. et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet \n                           10, 1215\u20131220, doi:10.1093\/hmg\/10.11.1215 (2001).","journal-title":"Hum Mol Genet"},{"key":"2455_CR2","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1161\/hc5001.102111","volume":"104","author":"MH Gollob","year":"2001","unstructured":"Gollob, M. H. et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. \n                           104, 3030\u20133033, doi:10.1161\/hc5001.102111 (2001).","journal-title":"Circulation."},{"key":"2455_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","volume":"45","author":"RT Murphy","year":"2005","unstructured":"Murphy, R. T. et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol. \n                           45, 922\u2013930, doi:10.1016\/j.jacc.2004.11.053 (2005).","journal-title":"J Am Coll Cardiol."},{"key":"2455_CR4","doi-asserted-by":"publisher","first-page":"e003121","DOI":"10.1161\/CIRCEP.115.003121","volume":"9","author":"AG Porto","year":"2016","unstructured":"Porto, A. G. et al. Clinical Spectrum of PRKAG2 Syndrome. Circ Arrhythm Electrophysiol. \n                           9, e003121, doi:10.1161\/CIRCEP.115.003121 (2016).","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"2455_CR5","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","volume":"344","author":"MH Gollob","year":"2001","unstructured":"Gollob, M. H. et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. \n                           344, 1823\u20131831, doi:10.1056\/NEJM200106143442403 (2001).","journal-title":"N Engl J Med."},{"key":"2455_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/JCI19874","volume":"113","author":"JW Scott","year":"2004","unstructured":"Scott, J. W. et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest. \n                           113, 274\u2013284, doi:10.1172\/JCI19874 (2004).","journal-title":"J Clin Invest."},{"key":"2455_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","volume":"33","author":"DG Hardie","year":"2015","unstructured":"Hardie, D. G. AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. \n                           33, 1\u20137, doi:10.1016\/j.ceb.2014.09.004 (2015).","journal-title":"Curr Opin Cell Biol."},{"issue":"Pt 3","key":"2455_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/bj3460659","volume":"346","author":"PC Cheung","year":"2000","unstructured":"Cheung, P. C., Salt, I. P., Davies, S. P., Hardie, D. G. & Carling, D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J. \n                           346(Pt 3), 659\u2013669, doi:10.1042\/bj3460659 (2000).","journal-title":"Biochem J."},{"key":"2455_CR9","doi-asserted-by":"publisher","first-page":"e64603","DOI":"10.1371\/journal.pone.0064603","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure. PLoS One \n                           8, e64603, doi:10.1371\/journal.pone.0064603 (2013).","journal-title":"PLoS One"},{"key":"2455_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI0214571","volume":"109","author":"M Arad","year":"2002","unstructured":"Arad, M. et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. \n                           109, 357\u2013362, doi:10.1172\/JCI14571 (2002).","journal-title":"J Clin Invest."},{"key":"2455_CR11","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/eurheartj\/ehu015","volume":"35","author":"EB Sternick","year":"2014","unstructured":"Sternick, E. B., de Almeida Araujo, S., Rocha, C. & Gollob, M. Myocardial infarction in a teenager. Eur Heart J. \n                           35, 1558\u20131558, doi:10.1093\/eurheartj\/ehu015 (2014).","journal-title":"Eur Heart J."},{"key":"2455_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1532-429X-14-13","volume":"14","author":"MS Maron","year":"2012","unstructured":"Maron, M. S. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. \n                           14, 13, doi:10.1186\/1532-429X-14-13 (2012).","journal-title":"J Cardiovasc Magn Reson."},{"key":"2455_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jcmg.2016.05.003","volume":"9","author":"BJ Maron","year":"2016","unstructured":"Maron, B. J. & Maron, M. S. The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR. JACC Cardiovasc Imaging. \n                           9, 858\u2013872, doi:10.1016\/j.jcmg.2016.05.003 (2016).","journal-title":"JACC Cardiovasc Imaging."},{"key":"2455_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1055\/s-0035-1555913","volume":"47","author":"S Mavrogeni","year":"2015","unstructured":"Mavrogeni, S., Markousis-Mavrogenis, G., Markussis, V. & Kolovou, G. The Emerging Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Metabolic Cardiomyopathies. Horm Metab Res. \n                           47, 623\u2013632, doi:10.1055\/s-0035-1555913 (2015).","journal-title":"Horm Metab Res."},{"key":"2455_CR15","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.jacc.2013.02.099","volume":"62","author":"E Fabris","year":"2013","unstructured":"Fabris, E. et al. Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. J Am Coll Cardiol. \n                           62, e17, doi:10.1016\/j.jacc.2013.02.099 (2013).","journal-title":"J Am Coll Cardiol."},{"key":"2455_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-015-0192-3","volume":"17","author":"P Poyhonen","year":"2015","unstructured":"Poyhonen, P. et al. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations. J Cardiovasc Magn Reson. \n                           17, 89, doi:10.1186\/s12968-015-0192-3 (2015).","journal-title":"J Cardiovasc Magn Reson."},{"key":"2455_CR17","doi-asserted-by":"publisher","unstructured":"Yogasundaram, H., Paterson, I. D., Graham, M., Sergi, C. & Oudit, G. Y. Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block. Circ Heart Fail. 9, doi:10.1161\/CIRCHEARTFAILURE.116.003367 (2016).","DOI":"10.1161\/CIRCHEARTFAILURE.116.003367"},{"key":"2455_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/CIRCRESAHA.111.255505","volume":"111","author":"VG Zaha","year":"2012","unstructured":"Zaha, V. G. & Young, L. H. AMP-activated protein kinase regulation and biological actions in the heart. Circ Res. \n                           111, 800\u2013814, doi:10.1161\/CIRCRESAHA.111.255505 (2012).","journal-title":"Circ Res."},{"key":"2455_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie, D. G., Schaffer, B. E. & Brunet, A. AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs. Trends Cell Biol. \n                           26, 190\u2013201, doi:10.1016\/j.tcb.2015.10.013 (2016).","journal-title":"Trends Cell Biol."},{"key":"2455_CR20","doi-asserted-by":"publisher","unstructured":"Thevenon, J. et al. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations. Europace, doi:10.1093\/europace\/euw067 (2016).","DOI":"10.1093\/europace\/euw067"},{"key":"2455_CR21","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1086\/430840","volume":"76","author":"B Burwinkel","year":"2005","unstructured":"Burwinkel, B. et al. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet. \n                           76, 1034\u20131049, doi:10.1086\/430840 (2005).","journal-title":"Am J Hum Genet."},{"key":"2455_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","volume":"11","author":"SA Hawley","year":"2010","unstructured":"Hawley, S. A. et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. \n                           11, 554\u2013565, doi:10.1016\/j.cmet.2010.04.001 (2010).","journal-title":"Cell Metab."},{"key":"2455_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1203\/PDR.0b013e3181462b86","volume":"62","author":"HO Akman","year":"2007","unstructured":"Akman, H. O. et al. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Pediatr Res. \n                           62, 499\u2013504, doi:10.1203\/PDR.0b013e3181462b86 (2007).","journal-title":"Pediatr Res."},{"key":"2455_CR24","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","volume":"107","author":"M Arad","year":"2003","unstructured":"Arad, M. et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation. \n                           107, 2850\u20132856, doi:10.1161\/01.CIR.0000075270.13497.2B (2003).","journal-title":"Circulation."},{"key":"2455_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.CIR.0000151291.32974.D5","volume":"111","author":"JS Sidhu","year":"2005","unstructured":"Sidhu, J. S. et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation. \n                           111, 21\u201329, doi:10.1161\/01.CIR.0000151291.32974.D5 (2005).","journal-title":"Circulation."},{"key":"2455_CR26","doi-asserted-by":"publisher","first-page":"H1942","DOI":"10.1152\/ajpheart.01020.2005","volume":"290","author":"JK Davies","year":"2006","unstructured":"Davies, J. K. et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol Heart Circ Physiol. \n                           290, H1942\u20131951, doi:10.1152\/ajpheart.01020.2005 (2006).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"2455_CR27","doi-asserted-by":"crossref","unstructured":"Gollob, M. H. Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome. Biochem Soc Trans. 31, 228\u2013231, doi:10.1042\/doi:10.1042\/ bst0310228 (2003).","DOI":"10.1042\/bst0310228"},{"key":"2455_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0735-1097(03)00850-7","volume":"42","author":"VV Patel","year":"2003","unstructured":"Patel, V. V. et al. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Am Coll Cardiol. \n                           42, 942\u2013951, doi:10.1016\/S0735-1097(03)00850-7 (2003).","journal-title":"J Am Coll Cardiol."},{"key":"2455_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1540-8167.2009.01578.x","volume":"21","author":"M Govindan","year":"2010","unstructured":"Govindan, M., Ward, D. & Behr, E. A rare connection: fasciculoventricular pathway in PRKAG2 disease. J Cardiovasc Electrophysiol. \n                           21, 329\u2013332, doi:10.1111\/j.1540-8167.2009.01578.x (2010).","journal-title":"J Cardiovasc Electrophysiol."},{"key":"2455_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.hrthm.2010.09.081","volume":"8","author":"EB Sternick","year":"2011","unstructured":"Sternick, E. B. et al. Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation. Heart Rhythm. \n                           8, 58\u201364, doi:10.1016\/j.hrthm.2010.09.081 (2011).","journal-title":"Heart Rhythm."},{"key":"2455_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/CIRCEP.108.782862","volume":"1","author":"HL Tan","year":"2008","unstructured":"Tan, H. L. et al. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development. Circ Arrhythm Electrophysiol. \n                           1, 276\u2013281, doi:10.1161\/CIRCEP.108.782862 (2008).","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"2455_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbadis.2009.12.001","volume":"1802","author":"SK Banerjee","year":"2010","unstructured":"Banerjee, S. K., McGaffin, K. R., Huang, X. N. & Ahmad, F. Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation. Biochim Biophys Acta. \n                           1802, 284\u2013291, doi:10.1016\/j.bbadis.2009.12.001 (2010).","journal-title":"Biochim Biophys Acta."},{"key":"2455_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/CIRCRESAHA.114.302364","volume":"114","author":"M Kim","year":"2014","unstructured":"Kim, M. et al. Mutation in the gamma2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Circ Res. \n                           114, 966\u2013975, doi:10.1161\/CIRCRESAHA.114.302364 (2014).","journal-title":"Circ Res."},{"key":"2455_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/europace\/eum071","volume":"9","author":"P Charron","year":"2007","unstructured":"Charron, P., Genest, M., Richard, P., Komajda, M. & Pochmalicki, G. A familial form of conduction defect related to a mutation in the PRKAG2 gene. Europace. \n                           9, 597\u2013600, doi:10.1093\/europace\/eum071 (2007).","journal-title":"Europace."},{"key":"2455_CR35","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"M Authors\/Task Force","year":"2014","unstructured":"Authors\/Task Force, M. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. \n                           35, 2733\u20132779, doi:10.1093\/eurheartj\/ehu284 (2014).","journal-title":"Eur Heart J."},{"key":"2455_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1532-429X-14-17","volume":"14","author":"RA Noureldin","year":"2012","unstructured":"Noureldin, R. A. et al. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. \n                           14, 17, doi:10.1186\/1532-429X-14-17 (2012).","journal-title":"J Cardiovasc Magn Reson."},{"key":"2455_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed, I. S. et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. \n                           3, 155\u2013164, doi:10.1016\/j.jcmg.2009.09.023 (2010).","journal-title":"JACC Cardiovasc Imaging."},{"key":"2455_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan, R. H. et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. \n                           130, 484\u2013495, doi:10.1161\/CIRCULATIONAHA.113.007094 (2014).","journal-title":"Circulation."},{"key":"2455_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira, M. D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. \n                           105, 539\u2013542, doi:10.1161\/hc0402.102975 (2002).","journal-title":"Circulation."},{"key":"2455_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10976640600572889","volume":"8","author":"AM Maceira","year":"2006","unstructured":"Maceira, A. M., Prasad, S. K., Khan, M. & Pennell, D. J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. \n                           8, 417\u2013426, doi:10.1080\/10976640600572889 (2006).","journal-title":"J Cardiovasc Magn Reson."},{"key":"2455_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/CIRCIMAGING.112.973560","volume":"5","author":"N Kawel","year":"2012","unstructured":"Kawel, N. et al. Normal left ventricular myocardial thickness for middle-aged and older subjects with steady-state free precession cardiac magnetic resonance: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. \n                           5, 500\u2013508, doi:10.1161\/CIRCIMAGING.112.973560 (2012).","journal-title":"Circ Cardiovasc Imaging."},{"key":"2455_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1532-429X-15-20","volume":"15","author":"J Wan","year":"2013","unstructured":"Wan, J. et al. Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction. J Cardiovasc Magn Reson. \n                           15, 20, doi:10.1186\/1532-429X-15-20 (2013).","journal-title":"J Cardiovasc Magn Reson."},{"key":"2455_CR43","doi-asserted-by":"publisher","unstructured":"Wu, W. et al. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing. J Am Heart Assoc. 4, doi:10.1161\/JAHA.115.001879 (2015).","DOI":"10.1161\/JAHA.115.001879"},{"key":"2455_CR44","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nprot.2015.105","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang, H. & Wang, K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. \n                           10, 1556\u20131566, doi:10.1038\/nprot.2015.105 (2015).","journal-title":"Nat Protoc."},{"key":"2455_CR45","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science. \n                           347, 1260419\u20131260419, doi:10.1126\/science.1260419 (2015).","journal-title":"Science."},{"key":"2455_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. \n                           14, 178\u2013192, doi:10.1093\/bib\/bbs017 (2013).","journal-title":"Brief Bioinform."},{"key":"2455_CR47","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet, F. O. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. \n                           37, e67\u2013e67, doi:10.1093\/nar\/gkp215 (2009).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02455-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T23:39:10Z","timestamp":1671752350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02455-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02455-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"assertion":[{"value":"6 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2407"}}